Mirum Pharmaceuticals, Inc. (MIRM)
93.33
-1.28
(-1.35%)
USD |
NASDAQ |
Nov 12, 16:00
93.25
-0.08
(-0.09%)
Pre-Market: 08:15
Mirum Pharmaceuticals Max Drawdown (5Y) : 50.92% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 50.92% |
| September 30, 2026 | 50.92% |
| August 31, 2026 | 50.92% |
| July 31, 2026 | 50.92% |
| June 30, 2026 | 50.92% |
| May 31, 2026 | 50.92% |
| April 30, 2026 | 50.92% |
| March 31, 2026 | 50.92% |
| February 28, 2026 | 50.92% |
| January 31, 2026 | 50.92% |
| December 31, 2025 | 50.92% |
| November 30, 2025 | 50.92% |
| October 31, 2025 | 50.92% |
| September 30, 2025 | 50.92% |
| August 31, 2025 | 50.92% |
| July 31, 2025 | 50.92% |
| June 30, 2025 | 50.92% |
| May 31, 2025 | 50.92% |
| April 30, 2025 | 50.92% |
| March 31, 2025 | 51.04% |
| February 28, 2025 | 63.78% |
| January 31, 2025 | 63.78% |
| December 31, 2024 | 63.78% |
| November 30, 2024 | 63.78% |
| October 31, 2024 | 63.78% |
| Date | Value |
|---|---|
| September 30, 2024 | 63.78% |
| August 31, 2024 | 63.78% |
| July 31, 2024 | 63.78% |
| June 30, 2024 | 63.78% |
| May 31, 2024 | 63.78% |
| April 30, 2024 | 63.78% |
| March 31, 2024 | 63.78% |
| February 29, 2024 | 63.78% |
| January 31, 2024 | 63.78% |
| December 31, 2023 | 63.78% |
| November 30, 2023 | 63.78% |
| October 31, 2023 | 63.78% |
| September 30, 2023 | 63.78% |
| August 31, 2023 | 63.78% |
| July 31, 2023 | 63.78% |
| June 30, 2023 | 63.78% |
| May 31, 2023 | 63.78% |
| April 30, 2023 | 63.78% |
| March 31, 2023 | 63.78% |
| February 28, 2023 | 63.78% |
| January 31, 2023 | 63.78% |
| December 31, 2022 | 63.78% |
| November 30, 2022 | 63.78% |
| October 31, 2022 | 63.78% |
| September 30, 2022 | 63.78% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Incyte Corp. | 58.51% |
| Galectin Therapeutics, Inc. | 88.76% |
| TG Therapeutics, Inc. | 93.19% |
| Ardelyx, Inc. | 95.65% |
| Kodiak Sciences, Inc. | 99.15% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 29.82 |
| Beta (5Y) | 0.7549 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 48.44% |
| Historical Sharpe Ratio (5Y) | 0.7435 |
| Historical Sortino (5Y) | 1.748 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 16.36% |